Related Experiment Video
Updated: Sep 8, 2025
08:50
Analysis of Beta-cell Function Using Single-cell Resolution Calcium Imaging in Zebrafish Islets
Published on: July 3, 2018
15.0K
From β soloist to endocrine symphony: Subtype-complete islets conduct glucose harmony
Jia Zhao1, Shenghui Liang1, Timothy J Kieffer2
1Life Sciences Institute, Department of Cellular & Physiological Sciences, University of British Columbia, Vancouver, BC, Canada.
Cell Stem Cell
|September 5, 2025
Summary
Researchers created complete pancreatic islets from stem cells. These islets restored natural blood sugar control and prevented hypoglycemia in diabetic mice, improving cell therapy for diabetes.
Area of Science:
- Endocrinology
- Stem Cell Biology
- Metabolic Disease Research
Background:
- Current stem cell therapies for diabetes often yield beta cell-rich islets.
- These therapies can successfully reverse hyperglycemia but may lead to dangerous hypoglycemia.
- A lack of endocrine diversity in engineered islets is a potential limitation.
Purpose of the Study:
- To engineer functionally complete pancreatic islets with diverse endocrine cell subtypes.
- To evaluate the efficacy of these complete islets in restoring physiological glucose regulation.
- To assess the protective effect against hypoglycemia in a diabetic mouse model.
Main Methods:
- Utilizing stem cell differentiation protocols to generate multiple pancreatic endocrine cell types.
- Reconstructing islets that mimic the natural endocrine composition.
- Implanting engineered islets into diabetic mouse models.
- Monitoring glycemic control and counterregulatory hormone responses.
Main Results:
- Engineered endocrine subtype-complete islets were successfully generated.
- Implanted islets restored robust counterregulatory responses to glucose fluctuations.
- The complete islets protected diabetic mice from hypoglycemia.
- This approach offers improved physiological regulation compared to beta cell-enriched islets.
Conclusions:
- Endocrine diversity is crucial for developing physiologically regulated cell therapies for diabetes.
- Reconstructing complete islets offers a promising strategy to overcome hypoglycemia associated with current stem cell treatments.
- This research advances the design of safer and more effective diabetes cell therapies.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:16Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K
01:16Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
01:02Glucose Homeostasis: Regulation of Blood Glucose
2.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.4K
01:24Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415